Aurion Biotech Named to Fast Company's Annual List of the World's Most Innovative Companies of 2025
Aurion Biotech, Inc. (Aurion Biotech), whose mission is to restore vision to millions of patients with life-changing regenerative therapies, today announced that the Company is proud to have been named to Fast Company 's prestigious list of the World's Most Innovative Companies of 2025. This year's list shines a spotlight on businesses that are shaping industry and culture through their innovations to set new standards and achieve remarkable milestones in all sectors of the economy. Alongside the World's 50 Most Innovative Companies, Fast Company recognizes 609 organizations across 58 sectors and regions. Aurion Biotech was named Number 4 in the Medicines, Therapeutics, and Pharmaceuticals category.
'We are delighted to have earned this recognition,' said Greg Kunst, CEO of Aurion Biotech. 'Aurion's success is a result of the passion, dedication, focus on patients and inspiring contributions of our employees and our physicians.'
Aurion Biotech has had a busy, productive 18 months. Key achievements included:
Enrolled and successfully dosed 97 subjects in its North American Phase 1/2 CLARA trial
Sought and received Breakthrough Therapy Designation and Regenerative Medicines Advanced Therapy designation from the U.S. Food and Drug Administration
Successfully dosed 25 subjects in the Company's Apaneca clinical trial, to evaluate the safety and efficacy of a cryo-preserved formulation of its drug product candidate
Fast Company's World's Most Innovative Companies hallmark franchise is one of its most anticipated editorial efforts of the year. To determine honorees, Fast Company' s editors and writers review companies driving progress around the world and across industries, evaluating thousands of submissions through a competitive application process. The result is a globe-spanning guide to innovation today, from early-stage startups to some of the most valuable companies in the world.
'Our list of the Most Innovative Companies offers both a comprehensive look at innovation today and a playbook for the future,' said Fast Company editor-in-chief Brendan Vaughan. 'This year, we recognize companies that are harnessing AI in deep and meaningful ways, brands that are turning customers into superfans by overdelivering for them, and challengers that are introducing bold ideas and vital competition to their industries. At a time when the world is rapidly shifting, these companies are charting the way forward.'
The full list of Fast Company's Most Innovative Companies honorees can now be found at fastcompany.com. It will also be available on newsstands beginning March 25.
Fast Company will host the Most Innovative Companies Summit and Gala for honorees on June 5. The summit features a day of inspiring content, followed by a creative black-tie gala including networking, a seated dinner, and an honoree presentation.
About Aurion Biotech, Inc.
Aurion Biotech's mission is to restore vision to millions of patients with life-changing regenerative therapies. It received the prestigious Prix Galien award for best start-up in biotech in 2022. Aurion Biotech is advancing AURN001, an investigational single administration, allogeneic cell therapy to treat corneal edema secondary to corneal endothelial dysfunction. Aurion Biotech developed and has launched the first commercially available corneal endothelial cell therapy in Japan. To learn more, visit www.aurionbiotech.com.
ABOUT FAST COMPANY
(corporate communications)
415-971-2900
[email protected] Gray
(ophthalmology media)
917-449-9250
[email protected] Keshishian
(biotech & business media)
917-912-7195
[email protected]
INDUSTRY KEYWORD: BIOTECHNOLOGY FDA HEALTH PHARMACEUTICAL OPTICAL
SOURCE: Aurion Biotech, Inc.
Copyright Business Wire 2025.
PUB: 03/18/2025 09:21 AM/DISC: 03/18/2025 09:22 AM
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
11 minutes ago
- Business Wire
TruBridge Announces Second Quarter 2025 Conference Call to Be Held Friday, August 8, 2025
MOBILE, Ala.--(BUSINESS WIRE)--TruBridge, Inc. (NASDAQ: TBRG), a healthcare solutions company, today announced that it will release its financial results for the second quarter ended June 30, 2025, on Thursday, August 7, 2025, after the market closes. The Company will host a conference call at 7:30 a.m. Central Time, 8:30 a.m. Eastern Time on Friday, August 8, 2025. To access this interactive teleconference, dial (877) 407-0890 and request connection to the TruBridge earnings conference call. A live broadcast of TruBridge's conference call will also be available online at the Company's investor relations website, The 30-day online replay will be available approximately an hour following the conclusion of the live broadcast. About TruBridge TruBridge proudly supports rural and community hospitals and providers in their efforts to stay strong, independent, and deeply rooted in the communities they serve. Backed by more than 45 years of healthcare experience and trusted by over 1,500 clients nationwide, we offer a mix of technology, services, and strategic expertise — including revenue cycle management, electronic health records (EHR) and analytics — all designed singularly for the realities of rural and community healthcare. With a steadfast commitment to keeping care local, TruBridge helps hospitals flourish as the economic heart of their communities, delivering high-quality, personal care close to home. For more information, visit
Miami Herald
an hour ago
- Miami Herald
The Friday Checkout: Why Sprouts' self-distribution expansion is timely
Distribution has been a hot-button issue for the grocery industry this year, with United Natural Foods, Inc.'s cybersecurity attack taking center stage along with C&S Wholesale Grocers' recent bid to acquire SpartanNash. With all eyes on the food supply chain, grocers' efforts to build out self-distribution networks couldn't be more timely. Self-distribution was a major talking point during Sprouts Farmers Market's second quarter earnings call earlier this week. Though UNFI's near shutdown was "minimally disruptive" to the fast-growing specialty grocer, according to CEO Jack Sinclair, its expanding self-distribution network is looking more and more appealing these days. It would enable the specialty grocer to have "more control over [its] supply chain while minimizing operations and supply chain risks," Sinclair told investors. Sprouts runs a network of distribution centers across its operating footprint, with around 80% of its stores located within 250 miles of one. The grocer is expanding that network, with a new DC set to open in Northern California next year. It's also bringing its fresh meat and seafood sourcing in-house, according to an April investor presentation. "We're going through a transition period," Sinclair said about the ongoing efforts to establish a more self-sufficient supply chain. He added that Sprouts will continue to take over distribution of "key product categories." Sprouts is far from the first food retailer to turn to self-distribution. Ahold Delhaize US, for example, has ADUSA Distribution as well as ADUSA Transportation to serve all of its stateside banners. This self-distribution push began in 2019 and, as of 2023, included around two dozen facilities along the East Coast. Walmart is also part of this trend. This year alone, the retailer opened its first owned-and-operated case-ready beef facility, purchased a distribution center in Utah and debuted a Sam's Club distribution center in Florida. Self-distribution is difficult to carry out for smaller, independent grocers that lack the resources to build and operate supply facilities. But for larger retailers, it can help save money and avoid catastrophe if third-party distributors can't deliver. In case you missed it FMI rolls out SNAP resource for its members FMI – The Food Industry Association announced Thursday it has created a resource for its members to track state policies relating to waivers that restrict certain foods from SNAP eligibility. The page provides individual food definitions for states that have received waivers as well as state communication strategies, implementation timelines and a state-by-state comparison showing how "candy" is defined. The trade group said it will keep the resource updated as information becomes available. DoorDash bolsters its grocery presence The e-commerce provider announced Tuesday the addition of six retailers to its platform. The newcomers include Bi-Rite Market and Lunardi's Markets in the San Francisco Bay Area, Superior Grocers in California and three grocers in Ohio: Dave's Markets, Dorothy Lane Market and Lucky's Markets. Whole Foods takes on "biodiversity highway initiative" On Tuesday, Whole Foods Market unveiled a partnership with Mad Agriculture to launch a national initiative aimed at reconstructing native ecosystems across farmland in the U.S. The program, which will begin in and around the Lowery Creek Watershed in Wisconsin, aims to buffer communities from flooding and erosion, improve soil and water health, and support pollinators and wildlife. Whole Foods said the creation of a 1,000-acre "biodiversity highway" will address issues such as disappearing biodiversity, declining soil health and weakening ability of land to withstand environmental stress. As part of the initiative, the Amazon-owned grocer has pledged up to $500,000 in matching funds to "catalyze $1 million in collective investment from food system stakeholders in 2025." Impulse find Stop & Shop makes a 'Happy' cameo Netflix's hit movie "Happy Gilmore 2" features a laundry list of star cameos, including Ben Stiller, rapper Eminem, NFL player Travis Kelce and pro golfers Scottie Scheffler and Rory McIlroy. And then there's our personal favorite: Stop & Shop. The Northeast grocery chain's Clifton, New Jersey, store plays a key role early on in the film. Happy Gilmore, played by Adam Sandler, is shown working in the store's produce department when a pesky customer starts prodding him about playing professional golf again. (Spoiler alert: Happy doesn't let the pestering go unpunished.) "We're grateful to be part of such a culturally relevant moment - and excited for viewers to spot our aisles in this laugh-out-loud sequel," Stop & Shop said in a LinkedIn update. The star turn will, no doubt, raise awareness of the grocer's brand. "Happy Gilmore 2" garnered 46.7 million views in its first three days on Netflix, according to Variety, marking the best opening performance ever for a Netflix film. Copyright 2025 Industry Dive. All rights reserved.
Yahoo
2 hours ago
- Yahoo
American Electric Power (AEP) Board Approves Quarterly Dividend
American Electric Power Company, Inc. (NASDAQ:) is one of the defensive stocks that billionaires are buying amid US trade tariff uncertainty. On July 22, the company's board of directors approved a regular quarterly dividend of $0.93 per share. The dividend is payable on September 10, 2025, to shareholders of record as of August 8, 2025. The dividend offering represents a yield of 3.43%. Its payment will mark 461 consecutive quarterly cash dividends, affirming American Electric Power's commitment to returning value to shareholders. The quarterly dividend comes on the heels of the company announcing plans to invest $54 billion through 2029 to enhance customer service. The investment will also be used to support the company's efforts to meet growing customer energy needs. American Electric Power Company, Inc. (NASDAQ:AEP) operates one of the nation's largest electric transmission networks. Its system comprises 40,000 line miles and over 225,000 miles of distribution lines. It provides power to over 5.6 million customers across 11 states. While we acknowledge the potential of AEP as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 11 Best 52-Week High Stocks to Buy Now and 10 Best Biotech Stocks to Buy According to Billionaire Steve Cohen. Disclosure: None. This article is originally published at Insider Monkey. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
